GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samchundang Pharm Co Ltd (XKRX:000250) » Definitions » Other Long Term Assets

Samchundang Pharm Co (XKRX:000250) Other Long Term Assets : ₩51,463 Mil (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Samchundang Pharm Co Other Long Term Assets?

Samchundang Pharm Co's other long-term assets for the quarter that ended in Mar. 2025 was ₩51,463 Mil.

Samchundang Pharm Co's quarterly other long-term assets increased from Sep. 2024 (₩48,591 Mil) to Dec. 2024 (₩51,458 Mil) and increased from Dec. 2024 (₩51,458 Mil) to Mar. 2025 (₩51,463 Mil).

Samchundang Pharm Co's annual other long-term assets increased from Dec. 2022 (₩46,992 Mil) to Dec. 2023 (₩57,806 Mil) but then declined from Dec. 2023 (₩57,806 Mil) to Dec. 2024 (₩51,458 Mil).

Samchundang Pharm Co Other Long Term Assets Historical Data

The historical data trend for Samchundang Pharm Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samchundang Pharm Co Other Long Term Assets Chart

Samchundang Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54,406.37 54,534.42 46,991.77 57,806.43 51,458.39

Samchundang Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60,350.54 52,633.11 48,590.80 51,458.39 51,462.71

Samchundang Pharm Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Samchundang Pharm Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Samchundang Pharm Co Ltd (XKRX:000250) » Definitions » Other Long Term Assets
Comparable Companies
XKRX:128940 XKRX:068760 XKRX:069620 XKRX:237690 XKRX:006280 XKRX:009420 XKRX:195940 XKRX:185750 XKRX:003090 XKRX:086450 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
1606-1 SeoCho-Dong, SeoCho-Gu, Seoul, KOR, 137-877
Website
http://www.scd.co.kr
Samchundang Pharm Co Ltd is engaged in manufacturing, distributing, importing, and exporting pharmaceuticals in South Korea. The company offers ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as gastro intestines and vitamins.

Samchundang Pharm Co Headlines

No Headlines